Global Artificial Intelligence (AI) in Clinical Trials Market
Report Includes
- In-depth analysis of the global market for artificial intelligence (AI) in pharmaceutical clinical trials
- Analyses of the global market trends, with historic revenue data from 2022 to 2024, estimates for 2025, and projections of CAGRs through 2030
- Estimates of the market’s size and revenue growth prospects, accompanied by a market share analysis by offerings, deployment type, trial phase, therapeutic area, end user and region
- Facts and figures pertaining to market dynamics, technological advances, regulations, prospects and the impacts of macroeconomic variables
- Impact analysis of U.S. tariff laws on AI in the clinical trials market
- Insights derived from Porter’s Five Forces model, as well as a global supply chain analysis
- A look at the regulatory landscape featuring key international and regional regulations and standards for AI adoption
- Evaluation of recent patent activity and key granted and published patents
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
- Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
- Profiles of the leading companies
Global Artificial Intelligence (AI) in Clinical Trials Market
